Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...

The National Advertising Division (NAD) has sided with Genomic Health in a challenge the Exact Sciences subsidiary brought ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

VML Health has stepped up its work on advanced technology, data and artificial-intelligence-enabled strategies by naming ...

Texas Attorney General Ken Paxton and Health Choice Alliance are accusing Eli Lilly of “incentivizing” providers in the state ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

Days after President Donald Trump called on drugmakers to offer direct-to-consumer distribution of their products in the U.S.

Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...

The rising bladder cancer star that is the combination of Pfizer and Astellas’ Padcev and Merck’s Keytruda is looking to set ...

With a landmark U.S. approval  Tuesday, Insmed is making waves with a new class of drug that’s also the first to be green lit ...

Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...